Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (7): 645-648.doi: 10.3969/j.issn.1000-6621.2021.07.001
Previous Articles Next Articles
Received:
2021-05-18
Online:
2021-07-10
Published:
2021-07-09
Contact:
GAO Qian
E-mail:qiangao@fudan.edu.cn
YANG Ting-ting, GAO Qian. The tuberculosis drug-resistance and transmission surveillance network based on whole genome sequencing data[J]. Chinese Journal of Antituberculosis, 2021, 43(7): 645-648. doi: 10.3969/j.issn.1000-6621.2021.07.001
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.07.001
[1] |
黄飞, 赵雁林. 加快结核病监测系统信息化建设. 中国防痨杂志, 2020, 42(7):649-652. doi: 10.3969/j.issn.1000-6621.2020.07.001.
doi: 10.3969/j.issn.1000-6621.2020.07.001 |
[2] |
李涛, 杜昕, 陈伟, 等. 中国结核病管理信息监测与监控的回顾与展望. 中国防痨杂志, 2020, 42(7):657-661. doi: 10.3969/j.issn.1000-6621.2020.07.003.
doi: 10.3969/j.issn.1000-6621.2020.07.003 |
[3] |
Zhao Y, Xu S, Wang L, et al. National survey of drug-resis-tant tuberculosis in China. N Engl J Med, 2012, 366(23):2161-2170. doi: 10.1056/NEJMoa1108789.
doi: 10.1056/NEJMoa1108789 URL |
[4] |
郑惠文, 赵雁林. 中国结核病耐药监测现状与监测体系建设. 中国实用内科杂志, 2015, 35(8):647-650. doi: 10.7504/nk2015070102.
doi: 10.7504/nk2015070102 |
[5] |
马爱静, 赵雁林. 耐药结核病的流行和监测现状. 中国抗生素杂志, 2018, 43(5):502-506. doi: 10.3969/j.issn.1001-8689.2018.05.002.
doi: 10.3969/j.issn.1001-8689.2018.05.002 |
[6] |
Yang C, Shen X, Peng Y, et al. Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study. Clin Infect Dis, 2015, 61(2):219-227. doi: 10.1093/cid/civ255.
doi: 10.1093/cid/civ255 URL |
[7] |
Yang C, Luo T, Shen X, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retros-pective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis, 2017, 17(3):275-284. doi: 10.1016/S1473-3099(16)30418-2.
doi: 10.1016/S1473-3099(16)30418-2 URL |
[8] |
Jiang Q, Liu Q, Ji L, et al. Citywide transmission of multidrug-resistant tuberculosis under China’s rapid urbanization: a retrospective population-based genomic spatial epidemiological study. Clin Infect Dis, 2020, 71(1):142-151. doi: 10.1093/cid/ciz790.
doi: 10.1093/cid/ciz790 pmid: 31504306 |
[9] |
Shea J, Halse TA, Lapierre P, et al. Comprehensive whole-genome sequencing and reporting of drug resistance profiles on clinical cases ofMycobacterium tuberculosis in New York State. J Clin Microbiol, 2017, 55(6):1871-1882. doi: 10.1128/JCM.00298-17.
doi: 10.1128/JCM.00298-17 URL |
[10] |
Coll F, McNerney R, Preston MD, et al. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med, 2015, 7(1):51. doi: 10.1186/s13073-015-0164-0.
doi: 10.1186/s13073-015-0164-0 URL |
[11] |
Pankhurst LJ, Del Ojo Elias C, Votintseva AA, et al. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med, 2016, 4(1):49-58. doi: 10.1016/S2213-2600(15)00466-X.
doi: S2213-2600(15)00466-X pmid: 26669893 |
[12] |
Walker TM, Kohl TA, Omar SV, et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis, 2015, 15(10):1193-1202. doi: 10.1016/S1473-3099(15)00062-6.
doi: 10.1016/S1473-3099(15)00062-6 URL |
[13] |
Takiff HE, Feo O. Clinical value of whole-genome sequencing of Mycobacterium tuberculosis. Lancet Infect Dis, 2015, 15(9):1077-1090. doi: 10.1016/S1473-3099(15)00071-7.
doi: 10.1016/S1473-3099(15)00071-7 URL |
[14] |
Nikolayevskyy V, Niemann S, Anthony R, et al. Role and value of whole genome sequencing in studying tuberculosis transmission. Clin Microbiol Infec, 2019, 25(11):1377-1382. doi: 10.1016/j.cmi.2019.03.022.
doi: 10.1016/j.cmi.2019.03.022 |
[15] |
Satta G, Lipman M, Smith GP, et al. Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential? Clin Microbiol Infect, 2018, 24(6):604-609. doi: 10.1016/j.cmi.2017.10.030.
doi: 10.1016/j.cmi.2017.10.030 URL |
[16] | Talarico S, Silk B, Shaw T, et al. Whole-genome sequencing for investigation of recent TB transmission in the United States: current uses and future plans[R/OL].[2021-05-18].https://www.cdc.gov/tb/programs/genotyping/Tuberculosis_WGS_Training_Module.pdf. |
[17] | European Centre for Disease Prevention and Control. Expert opinion on whole genome sequencing for public health surveillance. Stockholm: European Centre for Disease Prevention and Control, 2016. |
[18] | National TB Strategy team. Collaborative TB strategy for england, 2015 to 2020-end of programme report. London: Public Health England, 2020. |
[19] |
Tagliani E, Cirillo DM, Ködmön C, et al. EUSeqMyTB to set standards and build capacity for whole genome sequencing for tuberculosis in the EU. Lancet Infect Dis, 2018, 18(4):377. doi: 10.1016/S1473-3099(18)30132-4.
doi: S1473-3099(18)30132-4 pmid: 29582760 |
[20] |
Tagliani E, Anthony R, Kohl TA, et al. Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017—2019: an ECDC pilot study. Eur Respir J, 2021, 57(1):2002272. doi: 10.1183/13993003.02272-2020.
doi: 10.1183/13993003.02272-2020 |
[21] |
Kwong JC, McCallum N, Sintchenko V, et al. Whole genome sequencing in clinical and public health microbiology. Pathology, 2015, 47(3):199-210. doi: 10.1097/PAT.0000000000000235.
doi: 10.1097/PAT.0000000000000235 pmid: 25730631 |
[22] |
Meehan CJ, Goig GA, Kohl TA, et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol, 2019, 17(9):533-545. doi: 10.1038/s41579-019-0214-5.
doi: 10.1038/s41579-019-0214-5 |
[23] |
Walter KS, Colijn C, Cohen T, et al. Genomic variant-identification methods may alter Mycobacterium tuberculosis transmission inferences. Microb Genom, 2020, 6(8): mgen000418. doi: 10.1099/mgen.0.000418.
doi: 10.1099/mgen.0.000418 |
[24] |
CRyPTIC Consortium and the 100, 000 Genomes Project, Allix-Béguec C, Arandjelovic I, et al. Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing. N Engl J Med, 2018, 379(15):1403-1415. doi: 10.1056/NEJMoa1800474.
doi: 10.1056/NEJMoa1800474 URL |
[1] | QI Xue, WU Xi-rong, GUO Ya-jie, WANG Yong-hong, MA Qi, CHEN Yu-ying, SUN Lin, SHEN A-dong. Analysis of screening of latent tuberculosis infection in hospitalized children [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 653-658. |
[2] | ZHAO Guo-lian, TAN Xiao-wen, CUI Xiao-li, DANG Li-yun. Analysis of gene polymorphism of Mycobacterium tuberculosis with negative MPT64 antigen in culture filtrate [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 659-663. |
[3] | YI Jun-li, YANG Xin-yu, CHEN Hao, ZHAO Yan-feng, CHEN Shuang-shuang, ZHANG Jie, DING Bei-chuan, DAI Xiao-wei, SUN Shan-hua, WU Wen-qing, LI Chuan-you. Analysis of drug resistance of 1156 clinical isolates of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 677-681. |
[4] | CAO Pan, LIANG Kuang-li, YUAN Ji-xin, LI Yong-bo, CHEN Rui, ZHANG Zhi-fei, WU Qian-hong. Analysis of CT findings in patients with initial and retreated cavernous rifampicin-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 694-701. |
[5] | YAO Rong, LU Yu. Research and progress of early bactericidal activity of anti-tuberculosis drugs [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 724-728. |
[6] | CHANG Jun-li, ZHANG Jian-hong, ZHANG Ying, ZHANG Hai-fang, FAN Peng-fei, LI Qiu-hua, DING Xue-ling. Investigation and analysis of a cluster epidemic of rifampicin-resistant tuberculosis in a school [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 751-754. |
[7] | ZHANG Lei, LI Yuan-yuan, CHEN Xi, LIU Hai-ting, XU Jian, WANG Ning, DING Yang-ming, LU Yu. Study of the mechanism of the new antidrug-resistant tuberculosis drug pyrifazimine mediated by quinone oxidoreductase [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 576-583. |
[8] | LIN Jian, ZHAO Yong, DAI Zhi-song, WEI Shu-zhen, LIN Shu-fang. Identification and analysis of 261 strains of non-tuberculous mycobacteria in Fujian Province [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 590-595. |
[9] | LUO Dan, QIN Hui-fang, YE Jing, ZHAO Jin-ming, QIN Yi-xiang, LAN Ru-shu. Analysis on gene mutation characteristics of drug resistant Mycobacterium tuberculosis and its correlation with genotypes in Guangxi [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 596-601. |
[10] | WU Tuo-ya, SHI Jin, GUO Ji-dong, LIU Yuan-yuan, PANG Yu, LU Jie, GAO Fei. Mechanism of miR-21-3p modulating the survival of Mycobacterium tuberculosis in host macrophage [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 475-481. |
[11] | WANG Lu, XUE Zhong-tan, WANG Yu-feng, SHANG Yuan-yuan, REN Wei-cong, YAO Cong, GAO Fei, PANG Yu. A study of dynamic monitoring of drug sensitivity of Mycobacterium tuberculosis to bedaquiline and the mechanism of drug resistance [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 482-486. |
[12] | LIU Min, LI Ming-jun, YU Qing, HE Kun, WU Yu-shan, YANG Hong-hong, LI Tong-xin. Bacteria distribution and drug resistance of co-infection patients of human immunodeficiency virus and nontuberculous mycobacteria in Chongqing [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 501-505. |
[13] | FENG Bin-bin, JIN Feng, JING Hui, WANG Jun-ling, LIN Mei-ying, QIAO Xiu-li, LI Ming, QIU Li-hua. Identification and drug resistance of 439 clinical isolates of non-tuberculosis mycobacterium in Shandong [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 516-520. |
[14] | LI Jun, ZHANG Qing-ling, ZHANG Yu, YANG Shang-peng, ZHAO Jian, ZHANG Yun. Analysis of drug resistance of first-line anti tuberculosis drugs in Jingzhou City of Hubei Province from 2015 to 2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(5): 521-525. |
[15] | ZHANG Li-jie*, HAN Xi-qin, WANG Jing-ping, CHEN Yu-hui, CHEN Sheng-yu, CHEN Ling, LI Bo, LIN Ming-gui, LI You-lun, SHI Lian, XI Xiu-e, MA Li-ping, WANG Xin, WANG Fei, ZHAO Cai-yan, WANG Fu-rong, CHEN Sen-lin, WU Xiang, LI Po, ZHANG Peng, LENG Xue-yan, ZHANG Hai-qing, CAO Wen-li, SHU Wei, SUN Yu-xian, XIE Shi-heng, TIAN Xi-zhong, HUANG Xue-rui, DU Jian, GAO Wei-wei. The relationship between bacterial load and treatment failure and recurrence of sputum positive retreatment pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 335-340. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||